MedTrace Logo

Instant Flush Redness Clinical Efficacy Study

NCT07067476 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-16

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if an anti-redness emulsion can help lower facial redness caused by heat in healthy adult women. The main questions it aims to answer are:

* Does the anti-redness emulsion lower facial redness better than purified water?
* Is the product safe and comfortable to use?

Researchers will compare the anti-redness emulsion to purified water using a split-face method.

Participants will:

* Receive infrared light on their face to trigger redness
* Apply the anti-redness emulsion to one side of their face and purified water to the other side
* Have their facial redness measured at different time points using photography, imaging devices, and skin redness tests
* Answer questions about their experience with the products

Conditions

  • Sensitive Skin

Interventions

OTHER

Instant Anti-Redness Emulsion (FLA#2039188 43)

A topical emulsion not yet marketed, developed to relieve skin redness. It contains panthenol and is applied once to the test side of the face after heat-induced redness.

OTHER

Purified Water (Control)

0.3g of water is applied to the control side of the face. Used as placebo comparator to evaluate the redness-relieving efficacy of the test emulsion.

Sponsors & Collaborators

  • ChinaNorm

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-15
Primary Completion
2025-10-15
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07067476 on ClinicalTrials.gov